comprehensive -WSS

comprehensive

author：entertainment 2025-08-31 01:58:13 - browse：23957

empty test tubes in the hand. -- first opinion coverage from STAT — Adobe

The Food and Drug Administration on Friday announced its intention to start regulating tests developed in laboratories — closing the “Theranos loophole” that has allowed inaccurate tests to slip through the cracks.

Lawmakers came close last year to passing a bill that would have given the FDA this authority, but it was ultimately rejected by Republicans who sympathized with the labs in academic medical centers and hospitals that opposed the provision. FDA Commissioner Robert Califf said at the time that if the bill failed, the agency would take matters into its own hands.

The proposed rule fulfills that promise, adding lab diagnostics to the list of devices that fall under FDA enforcement — a move that patient groups and non-lab test makers support, and that laboratories are likely to dispute. When the FDA started regulating medical devices in 1976, lab-developed tests were simple and offered mostly to local patient populations. The agency generally allowed labs to use these tests without submitting proof of their efficacy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Humana’s losses in Medicare Advantage tank its stock

knowledge

WSS

Reconstructing family trees of blood cells may help predict disease

Merck, Johnson & Johnson CEOs will testify on high drug prices

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Readout Newsletter: The latest on Novavax, Merck, Bluebird

White House pharmacy plagued with problems, investigation finds

10 reasons why health care startups fail

explore

comprehensive

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Philips to halt sales of sleep apnea machines in U.S.

Trump demands the U.S. pay no more for drugs than other countries … again

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Duchenne breakthrough therapy leaves behind pioneering families

FDA advisory panel to debate high blood pressure devices

United colonoscopy coverage change 'may cost lives,' doctors say

National associations that represent hospice owe an apology

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How the drug

explore

California store owner shot dead in dispute over displaying Pride flag: Police

Kellogg’s is going to war over Mexico’s nutrition label rules

Kellogg’s is going to war over Mexico’s nutrition label rules

How the drug

How the drug

Intellia plays down concerns on accidental germline transmission

leisure time

leisure time

knowledge

explore